Half-year report · HY
4597.TEDINET S100YWKT
Period2026-01-01 → 2026-06-30
Filed2026-08-13
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥8m | 2026-01-01 → 2026-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥429m | 2025-01-01 → 2025-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥49m | 2025-01-01 → 2025-06-30 | Cons. | Revenue IFRS |
| Operating income | −¥570m | 2026-01-01 → 2026-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | −¥537m | 2025-01-01 → 2025-06-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | −¥579m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥876m | 2025-01-01 → 2025-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | −¥555m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | −¥579m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥876m | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | −¥555m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | −¥579m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss IFRS |
| Net income | −¥555m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss IFRS |
| Total assets | ¥1.9bn | at 2026-06-30 | Cons. | Assets IFRS |
| Total assets | ¥2.1bn | at 2025-12-31 | Cons. | Assets IFRS |
| Total assets | ¥1.9bn | at 2025-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥444m | at 2026-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥393m | at 2025-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.5bn | at 2026-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.8bn | at 2025-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.3bn | at 2025-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.2bn | at 2024-12-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥1.5bn | at 2026-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥1.8bn | at 2025-12-31 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥1.3bn | at 2025-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥1.3bn | at 2026-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥1.4bn | at 2025-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥1.5bn | at 2025-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥886m | at 2024-12-31v | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | −¥325m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | −¥847m | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | −¥32m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥34m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥81m | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥1m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥242m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥1.4bn | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥672m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥-2.14 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-3.69 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥-2.54 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥-2.14 | 2026-01-01 → 2026-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥-3.69 | 2025-01-01 → 2025-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥-2.54 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 76.6% | at 2026-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 81.7% | at 2025-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 68.5% | at 2025-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 484
| Item | Context | Value | Unit |
|---|---|---|---|
| Net cash provided by used in operating activities IFRS | Prior1InterimDuration | -32000000 | JPY |
| Net cash provided by used in operating activities IFRS | InterimDuration | -325000000 | JPY |
| Purchase of property plant and equipment inv cf IFRS | Prior1InterimDuration | -0 | JPY |
| Purchase of property plant and equipment inv cf IFRS | InterimDuration | -0 | JPY |
| Purchase of investment securities inv cf IFRS | Prior1InterimDuration | － | JPY |
| Purchase of investment securities inv cf IFRS | InterimDuration | -34000000 | JPY |
| Other inv cf IFRS | Prior1InterimDuration | -0 | JPY |
| Other inv cf IFRS | InterimDuration | -0 | JPY |
| Net cash provided by used in investing activities IFRS | Prior1InterimDuration | -1000000 | JPY |
| Net cash provided by used in investing activities IFRS | InterimDuration | -34000000 | JPY |
| Proceeds from issuance of shares fin cf IFRS | Prior1InterimDuration | 688000000 | JPY |
| Proceeds from issuance of shares fin cf IFRS | InterimDuration | 260000000 | JPY |
| Repayments of lease obligations fin cf IFRS | Prior1InterimDuration | -16000000 | JPY |
| Repayments of lease obligations fin cf IFRS | InterimDuration | -17000000 | JPY |
| Other fin cf IFRS | Prior1InterimDuration | 1000000 | JPY |
| Other fin cf IFRS | InterimDuration | -0 | JPY |
| Net cash provided by used in financing activities IFRS | Prior1InterimDuration | 672000000 | JPY |
| Net cash provided by used in financing activities IFRS | InterimDuration | 242000000 | JPY |
| Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRS | Prior1InterimDuration | 639000000 | JPY |
| Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRS | InterimDuration | -117000000 | JPY |
| Cash and cash equivalents IFRS | Prior2YearInstant | 886000000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 1387000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | Prior1InterimDuration | -39000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | InterimDuration | 19000000 | JPY |
| Cash and cash equivalents IFRS | Prior1InterimInstant | 1486000000 | JPY |
| Cash and cash equivalents IFRS | InterimInstant | 1289000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2026-08-13 | |
| Semi annual accounting period cover page | FilingDateInstant | Original text (Japanese)第19期中（自 2026年１月１日 至 2026年６月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ソレイジア・ファーマ株式会社 | |
| Company name in english cover page | FilingDateInstant | Solasia Pharma K.K. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 荒井 好裕 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都港区芝公園二丁目11番１号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 03-5843-8046 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)経理部長 嶌田 康光 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区芝公園二丁目11番１号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 03-5843-8046 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)経理部長 嶌田 康光 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E33044 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45970 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)ソレイジア・ファーマ株式会社 | |
| Filer name in english | FilingDateInstant | Solasia Pharma K.K. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |